Form 4 for SONM DNA X, Inc.
Accepted 2024-01-10 00:00:00 ET · period of report 2024-01-09 · accession 0001493152-24-001982 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-10 | 2024-01-09 | SONM | MULICA MICHAEL C | Dir | A - Grant | $0.00 | +66.7K | 385.2K | +21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-09 | A | A | 66,675 | $0.00 | 385,225 | D | — | — | (F1) Represents the grant of restricted stock units that vest in one installment on the earlier of November 12, 2024, a change in control of the Issuer, or the Reporting Person's death or disability. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. (F2) Consists of (i) 229,025 shares of common stock and (ii) 156,200 unvested restricted stock units. |